✦ LIBER ✦

The benefit of cholesterol-lowering medications after coronary revascularization: A population study

✍ Scribed by James M. Brophy; Paul Brassard; Chantal Bourgault

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

03P Dilution of the benefit from primary

✍ M. Cucherat; A. Leizorovicz 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 65 KB

Preventing recurrent events long term af

✍ P.J. Bradshaw; K. Jamrozik; I. Gilfillan; P.I. Thompson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Preventing recurrent events long term af

✍ Pamela J Bradshaw; Konrad Jamrozik; Ian Gilfillan; Peter L Thompson 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 160 KB

Association of chronic kidney disease wi

✍ Joachim H. Ix; Nestor Mercado; Michael G. Shlipak; Pedro A. Lemos; Eric Boersma; 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 347 KB

The effects of prophylactic coronary rev

✍ Elise Y. W. Wong; Herenia P. Lawrence; David T. Wong 📂 Article 📅 2007 🏛 Springer-Verlag 🌐 French ⚖ 513 KB

Effect of lipid-lowering therapy on earl

✍ Herbert D Aronow; Eric J Topol; Matthew T Roe; Penny L Houghtaling; Katherine E 📂 Article 📅 2001 🏛 The Lancet 🌐 English ⚖ 102 KB